Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 331

1.

Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses.

Treanor JJ, Kotloff K, Betts RF, Belshe R, Newman F, Iacuzio D, Wittes J, Bryant M.

Vaccine. 1999 Dec 10;18(9-10):899-906.

PMID:
10580204
[PubMed - indexed for MEDLINE]
2.

Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.

Fleming DM, Crovari P, Wahn U, Klemola T, Schlesinger Y, Langussis A, Øymar K, Garcia ML, Krygier A, Costa H, Heininger U, Pregaldien JL, Cheng SM, Skinner J, Razmpour A, Saville M, Gruber WC, Forrest B; CAIV-T Asthma Study Group.

Pediatr Infect Dis J. 2006 Oct;25(10):860-9.

PMID:
17006278
[PubMed - indexed for MEDLINE]
3.

Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.

Ashkenazi S, Vertruyen A, Arístegui J, Esposito S, McKeith DD, Klemola T, Biolek J, Kühr J, Bujnowski T, Desgrandchamps D, Cheng SM, Skinner J, Gruber WC, Forrest BD; CAIV-T Study Group.

Pediatr Infect Dis J. 2006 Oct;25(10):870-9.

PMID:
17006279
[PubMed - indexed for MEDLINE]
4.

Direct and total effectiveness of the intranasal, live-attenuated, trivalent cold-adapted influenza virus vaccine against the 2000-2001 influenza A(H1N1) and B epidemic in healthy children.

Gaglani MJ, Piedra PA, Herschler GB, Griffith ME, Kozinetz CA, Riggs MW, Fewlass C, Halloran ME, Longini IM Jr, Glezen WP.

Arch Pediatr Adolesc Med. 2004 Jan;158(1):65-73.

PMID:
14706961
[PubMed - indexed for MEDLINE]
5.

Effect of yearly vaccinations with live, attenuated, cold-adapted, trivalent, intranasal influenza vaccines on antibody responses in children.

Bernstein DI, Yan L, Treanor J, Mendelman PM, Belshe R; Cold-Adapted, Trivalent, Influenza Vaccine Study Group.

Pediatr Infect Dis J. 2003 Jan;22(1):28-34.

PMID:
12544405
[PubMed - indexed for MEDLINE]
6.

Use of live cold-adapted influenza A H1N1 and H3N2 virus vaccines in seropositive adults.

Treanor JJ, Roth FK, Betts RF.

J Clin Microbiol. 1990 Mar;28(3):596-9. Erratum in: J Clin Microbiol 1990 Jun;28(6):1491.

PMID:
2182673
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.

[No authors listed]

Drugs R D. 2003;4(5):312-9. Review.

PMID:
12952502
[PubMed - indexed for MEDLINE]
8.

Comparison of live, attenuated H1N1 and H3N2 cold-adapted and avian-human influenza A reassortant viruses and inactivated virus vaccine in adults.

Sears SD, Clements ML, Betts RF, Maassab HF, Murphy BR, Snyder MH.

J Infect Dis. 1988 Dec;158(6):1209-19.

PMID:
3198936
[PubMed - indexed for MEDLINE]
9.

Safety, efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children.

Belshe RB, Gruber WC.

Philos Trans R Soc Lond B Biol Sci. 2001 Dec 29;356(1416):1947-51.

PMID:
11779396
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Immunity to influenza in older adults with chronic obstructive pulmonary disease.

Gorse GJ, O'Connor TZ, Newman FK, Mandava MD, Mendelman PM, Wittes J, Peduzzi PN.

J Infect Dis. 2004 Jul 1;190(1):11-9. Epub 2004 May 26.

PMID:
15195238
[PubMed - indexed for MEDLINE]
Free Article
11.

Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine.

Belshe RB, Gruber WC, Mendelman PM, Cho I, Reisinger K, Block SL, Wittes J, Iacuzio D, Piedra P, Treanor J, King J, Kotloff K, Bernstein DI, Hayden FG, Zangwill K, Yan L, Wolff M.

J Pediatr. 2000 Feb;136(2):168-75.

PMID:
10657821
[PubMed - indexed for MEDLINE]
12.

Estimating efficacy of trivalent, cold-adapted, influenza virus vaccine (CAIV-T) against influenza A (H1N1) and B using surveillance cultures.

Halloran ME, Longini IM Jr, Gaglani MJ, Piedra PA, Chu H, Herschler GB, Glezen WP.

Am J Epidemiol. 2003 Aug 15;158(4):305-11.

PMID:
12915495
[PubMed - indexed for MEDLINE]
Free Article
13.

Immunization of institutionalized asthmatic children and patients with psychomotor retardation using live attenuated cold-adapted reassortment influenza A H1N1, H3N2 and B vaccines.

Miyazaki C, Nakayama M, Tanaka Y, Kusuhara K, Okada K, Tokugawa K, Ueda K, Shibata R, Nishima S, Yamane N, et al.

Vaccine. 1993;11(8):853-8.

PMID:
8356846
[PubMed - indexed for MEDLINE]
14.

Trivalent attenuated cold-adapted influenza virus vaccine: reduced viral shedding and serum antibody responses in susceptible adults.

Keitel WA, Couch RB, Quarles JM, Cate TR, Baxter B, Maassab HF.

J Infect Dis. 1993 Feb;167(2):305-11.

PMID:
8421165
[PubMed - indexed for MEDLINE]
15.
16.

Prospective, randomized, placebo-controlled evaluation of the safety and immunogenicity of three lots of intranasal trivalent influenza vaccine among young children.

Zangwill KM, Droge J, Mendelman P, Marcy SM, Partridge S, Chiu CY, Jing J, Chang SJ, Cho I, Ward JI.

Pediatr Infect Dis J. 2001 Aug;20(8):740-6.

PMID:
11734734
[PubMed - indexed for MEDLINE]
17.

Safety and immunogenicity of low and high doses of trivalent live cold-adapted influenza vaccine administered intranasally as drops or spray to healthy children.

King JC Jr, Lagos R, Bernstein DI, Piedra PA, Kotloff K, Bryant M, Cho I, Belshe RB.

J Infect Dis. 1998 May;177(5):1394-7.

PMID:
9593032
[PubMed - indexed for MEDLINE]
Free Article
18.

Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly.

Treanor JJ, Mattison HR, Dumyati G, Yinnon A, Erb S, O'Brien D, Dolin R, Betts RF.

Ann Intern Med. 1992 Oct 15;117(8):625-33.

PMID:
1530193
[PubMed - indexed for MEDLINE]
19.

Safety and immunogenicity of a live-attenuated influenza vaccine blended and filled at two manufacturing facilities.

Nolan T, Lee MS, Cordova JM, Cho I, Walker RE, August MJ, Larson S, Coelingh KL, Mendelman PM.

Vaccine. 2003 Mar 7;21(11-12):1224-31.

PMID:
12559802
[PubMed - indexed for MEDLINE]
20.

Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?

Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA.

Pediatrics. 2006 Sep;118(3):e570-8.

PMID:
16950948
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk